Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/26 19:35 | 1/15/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | 5 | P.m | 5,985 | 14.34 | 0 | 417 | 23 | 2,262 | I | |||||||||||||||
1/20/26 19:31 | 1/15/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Kutzkey Tim | CA | DT | 5 | P.m | 5,985 | 14.34 | 0 | 417 | 23 | 2,262 | I | |||||||||||||||
1/6/26 20:25 | 1/2/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Li Yang | CA | O | Exec. VP | 2 | M.d | 22 | 6.14 | 0 | 4 | 27 | 17 | D | ||||||||||||||
1/6/26 20:25 | 1/5/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Li Yang | CA | O | Exec. VP | 2 | S.d | -22 | 6.14 | 0 | -4 | 17 | D | |||||||||||||||
1/6/26 20:22 | 1/2/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Williams Charles O | CA | O | COO | 2 | M.d | 31 | 6.14 | 0 | 5 | 64 | 13 | D | ||||||||||||||
1/6/26 20:22 | 1/5/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Williams Charles O | CA | O | COO | 2 | S.d | -31 | 6.14 | 0 | -5 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |